Alkermes (ALKS) EBIAT (2010 - 2026)

Alkermes (ALKS) has 17 years of EBIAT data on file, last reported at $16.2 million in Q1 2026.

• EBIAT for Q1 2026 came in at $16.2 million, down 27.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $235.4 million (down 32.22% YoY), and the FY2025 annual result was $241.7 million, down 34.16% from the prior year.
• EBIAT slipped to $16.2 million in Q1 2026 per ALKS's latest filing, from $49.3 million in the prior quarter.
• Over five years, EBIAT peaked at $276.2 million in Q4 2023 and troughed at -$64.0 million in Q3 2022.
• A 5-year average of $65.0 million and a median of $49.3 million in 2025 frame the typical range for EBIAT.
• On a YoY basis, EBIAT climbed as much as 10995.19% in 2022 and fell as far as 1374.79% in 2022.
• A 5-year view of EBIAT shows it stood at $96.9 million in 2022, then soared by 185.13% to $276.2 million in 2023, then slumped by 49.07% to $140.7 million in 2024, then plunged by 64.92% to $49.3 million in 2025, then sank by 67.17% to $16.2 million in 2026.
• Business Quant data shows ALKS's EBIAT at $16.2 million in Q1 2026, $49.3 million in Q4 2025, and $82.8 million in Q3 2025.